US Pre-Market SEC Filings Roundup — March 06, 2026

06-03-2026

Quipt Home Medical Corp. announced it obtained a final order from the Supreme Court of British Columbia approving its previously announced plan of arrangement (the 'Arrangement') under the Arrangement Agreement dated December 14, 2025, with 1567208 B.C. Ltd. and REM Aggregator, LLC. The transaction remains subject to customary closing conditions and is expected to complete by March 16, 2026, after which Quipt's common shares will be delisted from the Toronto Stock Exchange (TSX) and Nasdaq Capital Market (NASDAQ). No financial metrics were disclosed in the filing.

• ·Filing submitted on March 6, 2026, reporting event dated March 5, 2026.
• ·Press release attached as Exhibit 99.1.

06-03-2026

On February 17, 2026, Addentax Group Corp. agreed to purchase 34,200,000 common shares of KEEMO Fashion Group Ltd from Guang Wen Global Limited for approximately $5.5 million, satisfied by transferring a portion of an existing $17.5M bond originally issued on August 24, 2023. The deal is set to close by May 1, 2026, positioning Addentax as the controlling shareholder with 62.18% of voting rights on a fully-diluted basis. This 8-K/A filing corrects a tagging error in the original February 19, 2026 submission under Item 8.01.

• ·Shares have par value of $0.001 per share.
• ·Bond bears 2.5% per annum interest, one-year tenor (renewable), governed by New York law.
• ·Stock Purchase Agreement dated February 17, 2026 (Exhibit 10.1); Bond Transfer Agreement dated February 18, 2026 (Exhibit 10.2).

06-03-2026

BP's 2025 sales and other operating revenues remained essentially flat at $189.3B compared to $189.2B in 2024, while underlying RC profit declined 16% YoY to $7.5B amid weaker performance across segments. Net debt improved slightly to $22.2B from $23.0B, supporting progress toward the $14-18B target by end-2027, and total dividends distributed rose modestly to $5.1B from $5.0B. However, upstream production dropped 12% YoY to 785 mboe/d, proved reserves fell 9% to 1,198 mmboe, ROACE was 13.9% missing the >16% 2027 target, and employee engagement score declined to 66% from 70%.

• ·2026 guidance: Upstream reported production slightly lower/underlying broadly flat vs 2025 (2025 actual 2.3 mmboe/d); Total capex $13-13.5B; Divestments $9-10B; Gulf of America oil spill payments ~$1.6B pre-tax.
• ·Primary targets progress: Adjusted free cash flow growth >20% CAGR 2024-27 (2025 data not specified); Structural cost reduction $2.8B cumulative since 2023 vs $5.5-6.5B by end-2027.
• ·Adjusting items before tax: Net impairment and losses on sale $(6,035)M in 2025.

06-03-2026

Seaboard Corporation's DEF 14A proxy statement solicits votes for its 2026 Annual Meeting on April 20, 2026, at 8:30 a.m. local time at the DoubleTree Hotel in Overland Park, Kansas, to elect five directors until 2027, approve on an advisory basis the compensation of Named Executive Officers, and ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is February 19, 2026, with 957,794 shares of common stock outstanding, requiring a quorum of 478,898 shares. Principal stockholder Ellen S. Bresky beneficially owns 714,040.24 shares or 74.5%, primarily through Seaboard Flour LLC (358,068.69 shares, 37.4%) and SFC Preferred, LLC (346,155.55 shares, 36.1%).

• ·Annual Meeting location: DoubleTree Hotel, 10100 College Boulevard, Overland Park, Kansas 66210.
• ·Voting on director election requires plurality of votes cast; withhold and broker non-votes have no effect.
• ·Advisory vote on NEO compensation and auditor ratification each require majority of shares present and voting; abstentions treated as against.
• ·Proxy materials available at https://www.seaboardcorp.com/investors.
• ·Company address: 9000 West 67th Street, Merriam, Kansas 66202.

06-03-2026

06-03-2026

Oxford Square Capital Corp.'s investment portfolio ended 2025 at $251.7M, down 3.4% from $260.9M at end-2024, driven by $92.1M acquisitions (down 18% YoY), net unrealized depreciation of $24.3M (vs. $75.7M gain prior year), and realized losses of $16.8M. NAV per share declined from $2.09 in Q1 FY25 to $1.69 in Q4 FY25 amid stock prices trading at premiums to discounts relative to NAV, while quarterly distributions remained stable at $0.105 per share. Debt portfolio at Dec 31, 2025 showed 83.7% fair value in Grade 2 but 16.3% in Grade 3 requiring closer monitoring, with no Grade 4/5 investments.

• ·Year 1 incentive fee: Total Capital Gains Incentive Fee = 0% paid to Oxford Square Management.
• ·Year 2 incentive fee example: 1.6% paid (20% of 8% net capital gains).
• ·Year 3 incentive fee example: 2.0% paid (20% of 10% net capital gains).
• ·2025 portfolio sales: HealthChannels $8.2M, Quest Software $1.6M, Alvaria $1.0M.
• ·Q4 FY26 (through Mar 2, 2026) stock: High $1.98, Low $1.72, Distribution $0.105.

06-03-2026

Monroe Capital Corp (MRCC) filed a DEFA14A additional proxy statement on March 6, 2026, serving as a supplement that incorporates by reference its Annual Report on Form 10-K for the period ended December 31, 2025 (filed March 5, 2026) and a Current Report on Form 8-K filed January 15, 2026. The filing also references similar documents from HRZN, including its DEFA14A filed March 3, 2026, and an 8-K filed February 11, 2026. No financial metrics or performance data are disclosed in this procedural filing.

06-03-2026

MarketWise, Inc. reported total net revenue of $328.1M for 2025, down 19.7% YoY from $408.7M in 2024 and continuing an 8.8% decline from 2023's $448.2M, while billings rose 13.5% to $271.2M. Operating expenses decreased 16.9% to $265.5M, supporting a 19.1% operating margin (down slightly from 21.8% in 2024 but up from 11.6% in 2023), and net cash from operating activities swung to positive $46.0M from negative $22.2M. Net income attributable to MarketWise was $5.6M, a 20.4% decline from $7.1M in 2024 but up sharply from $1.8M in 2023.

• ·Related party revenue declined to $2.4M in 2025 from $3.3M in 2024 and $4.9M in 2023.
• ·Sales and marketing expenses fell 18.5% YoY to $131.0M in 2025, representing 39.9% of revenue (flat vs prior year).
• ·Impairment losses dropped sharply 91.5% to $0.4M in 2025 from $4.4M in 2024.
• ·Net income attributable to noncontrolling interests was $58.4M in 2025, down from $86.0M in 2024.

06-03-2026

Waste Connections, Inc. announced plans to offer senior unsecured notes in a public offering, subject to market and other conditions, with proceeds intended to repay a portion of borrowings under its revolving credit facility. BofA Securities, J.P. Morgan, PNC Capital Markets LLC, and Truist Securities are acting as joint book-running managers. No specific offering size or terms were disclosed, and the offering is pursuant to a shelf registration statement filed on October 24, 2024.

• ·Serves customers across 46 U.S. states and six Canadian provinces
• ·Shelf registration statement filed with SEC on October 24, 2024

06-03-2026

For the year ended December 31, 2025, Unknown Company reported total revenues of $592.3M, up 12.6% YoY from $525.9M, with rental revenues growing 11.6% and property NOI increasing 12.1% to $409.9M, while Aggregate Fund NAV rose to $5.01B from $4.33B. However, net loss attributable to common stockholders widened 12.3% to $124.8M from $111.1M, driven by higher interest expense (up 7.5%) and a 98.7% drop in equity income from joint ventures, with no real estate sale gains compared to $56.9M prior year. FFO improved 37.6% to $143.3M, but total returns were mixed, including negative one-year trailing returns of -2.84% for Class T-R shares (with sales charge).

• ·Cash provided by operating activities increased to $98.8M from $66.1M YoY.
• ·Same store rental revenues grew 5.6% YoY to $498.3M.
• ·Total stockholders’ equity under GAAP was $1.54B as of Dec 31, 2025.
• ·AFFO was $104.9M for 2025, up from $76.9M in 2024.

06-03-2026

Ares Real Estate Income Trust Inc. (ZARE) reported strong portfolio growth with total investments rising 28% YoY to $8.5B as of Dec 31, 2025, driven by industrial (+43%) and other properties, alongside total revenues up 19.5% YoY to $499M and property NOI increasing 21.6% to $285M. However, the company posted a widened net loss of $127M (vs $57M in 2024), with net loss to common stockholders at $68M and EPS at $(0.37); same-store NOI declined 2.1% YoY to $213M amid residential NOI down 6.9% and flat/slight declines in other segments. FFO dropped sharply to $16M from $89M, while AFFO fell to $27M from $40M.

• ·Cash from operating activities improved to $254M from negative $169M YoY.
• ·Interest expense increased 33.5% YoY to $251M.
• ·Same store average percentage leased: Residential 92.5% (up from 92.0%), Office 77.7% (down from 78.2%).
• ·Total stockholders' equity $655M as of Dec 31, 2025.

06-03-2026

NewLake Capital Partners, Inc. (NLCP) reported FY2025 total revenue of $51.1M, up 1.9% YoY from $50.1M, driven by slight increases in rental income (+1.2%) and fees, with net income attributable to common stockholders rising 0.8% YoY to $26.3M and AFFO up marginally to $43.8M. However, total assets declined 2.5% YoY to $420.8M from $431.5M, net real estate assets fell 4.3% to $370.0M primarily due to $15.5M depreciation, and net cash from operations dipped 2.1% to $42.5M. The portfolio totals $458M in investments across 1.7M sq ft, with 63.5% of rents from leases expiring after 2035 but 30.6% exposed in 2034.

• ·Vacant properties include Massachusetts (145,852 sq ft), Nevada (56,536 sq ft), and Pennsylvania (38,031 sq ft).
• ·Revolving Credit Facility unchanged at $7.6M.
• ·Accumulated Depreciation increased to $57.9M from $44.7M.
• ·Loan Receivable net $4.9M with Current Expected Credit Loss of $71K.
• ·Annualized Base Rent per Leased Square Foot weighted average $32.11.

06-03-2026

ReserveOne Holdings, Inc. (Pubco), a wholly-owned subsidiary of ReserveOne, Inc., disclosed communications via X, LinkedIn, and an interview at the Hong Kong DAT Summit regarding its proposed business combination with M3-Brigade Acquisition V Corp., originally agreed on July 7, 2025. CEO Jaime Leverton positioned ReserveOne as the only diversified digital asset treasury company set to go public, with ~80% allocation to Bitcoin and the balance to yield-generating altcoins like Ethereum and Solana. While highlighting investor exposure to the broader crypto ecosystem, extensive forward-looking risks were noted, including deal completion uncertainties, high crypto volatility, regulatory hurdles, and potential high redemptions.

• ·Business Combination Agreement entered July 7, 2025
• ·Communications posted March 5, 2026
• ·SEC Commission File No. 333-291982 for M3-Brigade
• ·Registration Statement on Form S-4 filed, including proxy statement/prospectus

06-03-2026

APEX Tech Acquisition Inc. consummated its initial public offering (IPO) on February 27, 2026, selling 11,197,131 public units at $10.00 each, generating gross proceeds of $111.97M. Simultaneously, the company closed a private placement of 208,971 units to its sponsor, APEX INNOVATION ACQUISITION CORP., for $2.09M in proceeds. A total of $111.97M in net proceeds from both transactions was deposited into a trust account for the benefit of public shareholders.

• ·Audited balance sheet as of February 27, 2026 included as Exhibit 99.1
• ·Securities traded on The New York Stock Exchange
• ·Company address: 13501 Katy Fwy, Houston, TX 77079

06-03-2026

Willow Lane Acquisition Corp. filed a Rule 425 communication highlighting a case study on Boost Run's rapid launch of a GPU-native managed Kubernetes service in under 45 days using vCluster, managing 1K+ GPUs without requiring new platform engineering hires. This underscores Boost Run's operational efficiency and enterprise-grade capabilities (SOC 2, ISO 27001, ISO 27701, HIPAA certified) ahead of their business combination originally agreed on September 15, 2025. No financial metrics or performance declines were disclosed.

• ·Case study published March 5, 2026; SEC filing date March 6, 2026
• ·Boost Run certifications: SOC 2, ISO 27001, ISO 27701, HIPAA
• ·Upcoming SEC filings: Registration Statement on Form S-4 including proxy statement/prospectus
• ·Business Combination Agreement dated September 15, 2025

06-03-2026

Granite Ridge Resources reported revenues of $450.3M for 2025, up 18% YoY from $380.0M, driven by strong production growth of 28% to 11.7 MBo e with oil volumes up 31% and net producing wells up 21% to 245. However, lower average oil prices ($61.63/Bbl, down 16% YoY) and higher lease operating expenses per Boe ($7.27, up 16%) contributed to a 22% decline in net operating income to $46.4M and impairments rising to $44.7M; net income rose 30% YoY to $24.4M but was down 70% from 2023 levels amid increased debt to $385M.

• ·Net cash used in investing activities increased to $410M in 2025 from $311M in 2024 due to higher capex.
• ·Long-term debt rose to $368M at Dec 31 2025 from $205M at Dec 31 2024.
• ·Retained earnings turned negative at -$17.3M at Dec 31 2025 after $57.7M dividend declaration.
• ·Equity investments declined to $11M current + $0 long-term at Dec 31 2025 from $32M + $0.
• ·Common stock dividend declared at $0.44 per share for 2025.

06-03-2026

On March 5, 2026, Liberty Live Holdings, Inc. announced that Renee L. Wilm will transition from her role as Chief Legal Officer and Chief Administrative Officer to Senior Advisor, effective later this year. In her new position, Ms. Wilm will continue providing strategic guidance and counsel to the leadership team while supporting key initiatives. The announcement was made by Liberty Media Corporation.

• ·Event reported date: March 5, 2026
• ·Filing date: March 6, 2026
• ·Securities registered: Series A Liberty Live Group Common Stock (LLYVA) and Series C (LLYVK) on Nasdaq Stock Market LLC
• ·Registrant is an emerging growth company

06-03-2026

On March 5, 2026, Liberty Broadband Corporation announced that Renee L. Wilm will transition from her role as Chief Legal Officer and Chief Administrative Officer to Senior Advisor, effective later this year. In her new role, Ms. Wilm will continue providing strategic guidance and counsel to the leadership team while supporting key initiatives. No other changes or financial impacts were disclosed.

• ·Announcement made by Liberty Media Corporation.
• ·Transition effective later in 2026.

06-03-2026

Liberty Media Corporation announced on March 5, 2026, that Renee L. Wilm will transition from her roles as Chief Legal Officer and Chief Administrative Officer across Liberty Media, Liberty Live Holdings, Inc., and Liberty Broadband Corporation to Senior Advisor effective later this year. In her new role, she will continue providing strategic guidance and counsel while supporting key initiatives. She will remain Chief Legal Officer at GCI Liberty, Inc., with no immediate disruptions or financial impacts disclosed.

06-03-2026

Canadian Imperial Bank of Commerce (CIBC) filed a Form F-3 registration statement with the SEC on March 5, 2026, to register up to $20 billion in senior debt securities for potential sale on a delayed or continuous basis pursuant to Rule 415, with specific terms to be detailed in future prospectus supplements. The filing highlights risks including geopolitical tensions, regulatory changes, and cyber threats, but provides no current financial performance metrics or period-over-period comparisons. Securities are not insured by CDIC or FDIC and may be subject to bail-in conversion under Canadian law.

• ·Registrant address: 81 Bay Street, CIBC Square, Toronto, Ontario, Canada M5J 0E7
• ·U.S. agent for service: 300 Madison Avenue, 6th Floor, New York, New York 10017
• ·Securities may be bail-inable under subsection 39.2(2.3) of the CDIC Act

06-03-2026

Pattern Group Inc. (PTRN) reported strong revenue growth of 39.3% YoY to $2.5B in 2025 from $1.8B in 2024, with cost of goods sold up 39.0% and sales & marketing expenses rising 46.8%. However, profitability declined sharply as net income fell to $16.2M from $67.9M, operating income dropped to $25.4M from $87.2M, and operating margin compressed to 1.0% from 4.9% amid higher operating expenses reaching 99.0% of revenue. Adjusted EBITDA improved to $152.9M from $100.7M, supported by a $104.3M share-based compensation charge and a $32.7M stock amendment expense.

• ·Net cash provided by operating activities increased to $99.4M in 2025 from $70.3M in 2024.
• ·Net cash used in investing activities doubled to $39.8M in 2025 from $20.4M in 2024.
• ·Net cash provided by financing activities swung to $53.7M inflow in 2025 from $2.9M outflow in 2024.
• ·2025 provision (benefit) for income taxes was ($17.0M) compared to $23.4M in 2024.
• ·2023 Adjusted EBITDA was $64.7M and net income $41.3M.

06-03-2026

On March 5, 2026, PROCEPT BioRobotics Corporation's board of directors increased its size from eight to nine members and appointed Daniel Puckett as a new Class III director, effective immediately, also naming him to the Audit Committee. Puckett, determined to be independent under SEC and Nasdaq rules, brings extensive CFO experience from Shockwave Medical, Inc. and other firms. His term expires at the 2027 annual stockholder meeting, with standard non-employee director compensation and indemnification.

• ·Puckett served as CFO of Shockwave Medical from April 2016 to February 2024.
• ·No arrangements or understandings for his appointment; no reportable transactions under Item 404(a) of Regulation S-K.
• ·Proxy statement on non-employee director compensation filed April 25, 2025; indemnification agreement form from S-1/A filed September 8, 2021.

06-03-2026

Dave Inc. priced a $175 million (upsized from $150 million) offering of 0% Convertible Senior Notes due 2031, expecting $168 million in net proceeds (or $192.1 million if the $25 million option is exercised fully), to be used for $15.1 million in capped call transactions, $70.5 million to repurchase 334,000 shares, and general corporate purposes including additional repurchases. The notes feature an initial conversion price of $279.13 per share (32.5% premium over $210.67 closing price on March 4, 2026) and a capped call cap price of $421.34 (100% premium). No performance declines noted, but capped calls aim to mitigate dilution risks from potential conversions.

• ·Offering expected to close on March 9, 2026, subject to customary conditions.
• ·Notes mature on April 1, 2031; redeemable after April 6, 2029 under specific conditions.
• ·Initial conversion rate: 3.5825 shares per $1,000 principal amount.

06-03-2026

Chime Financial reported total revenue of $2.19B for the year ended December 31, 2025, up 31% YoY from $1.67B in 2024, driven by 73% growth in platform-related revenue to $686M and 18% increase in payments revenue to $1.50B, alongside 19% growth in active members to 9.5M and 16% rise in purchase volume to $134B. However, net loss ballooned to $1.01B from $25M due to a surge in stock-based compensation to $1.09B and transaction/risk losses more than doubling to $407M, with transaction margin declining to 69% from 74%; operating expenses swelled to $2.96B, particularly in technology/development (+202% to $935M). Adjusted EBITDA improved to positive $127M (6% margin) from a $7M loss.

• ·Gross margin remained flat at 88% YoY.
• ·Cost of revenue increased 27% YoY to $263M.
• ·Technology and development expenses rose 202% YoY to $935M.
• ·Net loss per share diluted: $(4.27) in 2025 vs $(0.39) in 2024.
• ·ARPAM increased 5% YoY to $257.

06-03-2026

Nortech Systems Incorporated entered into Waiver and Amendment No. 4 to its Credit Agreement with Bank of America, N.A. on February 27, 2026, waiving financial covenant defaults on Consolidated Leverage Ratio, Fixed Charge Coverage Ratio, and Consolidated EBITDA for the quarter ended December 31, 2025. The amendment revises definitions, borrowing base, covenants, commitment levels, borrowing rates, and limits on foreign investments, signaling ongoing financial pressures despite positive operating benefits from prior restructurings. The company is negotiating a new asset-backed lending facility expected to close soon.

• ·Restructuring activities conducted in Q4 2024 and Q1 2025
• ·Waiver and Amendment filed as Exhibit 10.1

06-03-2026

News Corporation filed an 8-K on March 6, 2026, reporting on its ongoing $1B stock repurchase program authorizing acquisitions of Class A (NWSA) and Class B (NWS) common stock. The filing attaches Exhibits 99.1 and 99.2 with information provided to the Australian Securities Exchange (ASX) on respective dates, fulfilling daily disclosure requirements under ASX rules. No specific repurchase transactions are detailed in the filing body.

• ·Securities: Class A Common Stock (NWSA, par value $0.01) and Class B Common Stock (NWS, par value $0.01), traded on Nasdaq Global Select Market
• ·Event date: March 5, 2026; Filing date: March 6, 2026

06-03-2026

Tri Pointe Homes, Inc. (TPH) filed a DEFA14A Definitive Additional Materials proxy statement on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee required and contains no substantive proposals, financial data, or voting items in the provided excerpt. No performance metrics, positive or negative, are disclosed.

• ·Filed by the Registrant (☒)
• ·Definitive Additional Materials (☒)
• ·No fee required (☒)

06-03-2026

Crown PropTech Acquisitions entered into Non-Redemption Agreements with certain investors on March 5, 2026, whereby its sponsor, CIIG Management III LLC, will assign economic interests in one Class B ordinary share for each 40 public shares not redeemed at the March 9, 2026 Extraordinary General Meeting (EGM). These agreements aim to increase funds remaining in the trust account post-EGM by discouraging redemptions, supporting approval of a 12-month extension of the initial business combination deadline from March 11, 2026 to March 11, 2027, though they are not expected to affect approval likelihood. The sponsor holds 5,662,000 Class B ordinary shares, of which 2,194,988 are already subject to prior similar agreements.

• ·EGM record date: February 13, 2026
• ·Proxy Statement filed with SEC: February 27, 2026
• ·Assignment accrues monthly beginning April 11, 2026 until business combination completion
• ·Transfer of assigned shares conditioned on business combination closing and execution of Joinder to January 17, 2023 Letter Agreement

06-03-2026

Guidewire Software reported strong H1 FY26 revenue growth of 25% YoY to $692M, driven by 32% increase in subscription and support revenue to $459M, achieving net income of $91M versus a $28M loss in H1 FY25. However, license revenue remained essentially flat at $101M YoY for H1 and declined 7% in Q2, while services showed negative gross profit in Q2; cash and equivalents dropped $290M to $408M amid investing outflows and $148M stock repurchases. Total assets slightly declined to $2.69B from $2.72B.

• ·Operating cash flow increased to $44.6M from $23.7M YoY for H1.
• ·Stock-based compensation expense $90.1M for H1 FY26 vs $79.0M prior.
• ·Business acquisition for $33.3M net of cash in H1 FY26.
• ·Convertible senior notes net $676.3M as of Jan 31, 2026.

06-03-2026

On March 5, 2026, Spirit Aviation Holdings, Inc. entered into a Consent and Waiver with certain holders of its common stock and warrants, who represent a majority of Registrable Securities, waiving rights under Sections 2.1, 2.2, and 2.3 of the March 12, 2025 Registration Rights Agreement to permit the company to terminate the Form S-1 registration statement (File No. 333-288706). This action occurs during the company's ongoing Chapter 11 bankruptcy cases filed on August 29, 2025, with explicit warnings that trading in common stock is highly speculative and could result in significant or complete loss for holders.

06-03-2026

Cresco Labs Inc., a foreign private issuer, filed its Form 40-F annual report for FY2025 ended December 31, 2025, incorporating the AIF, MD&A, and audited consolidated financial statements for 2025 and 2024. Management concluded that disclosure controls and procedures were not effective, and material weaknesses persist in internal control over financial reporting (ICFR) related to IT general controls in program change-management and job monitoring, despite remediation of prior weaknesses in logical access, service organization controls, and account reconciliations. As of December 31, 2025, the company had 158,940,757 Special Subordinate Voting Shares, 343,232,815 Subordinate Voting Shares, 81,492 Proportionate Voting Shares, and 500,000 Super Voting Shares outstanding.

• ·Material weaknesses in ICFR due to ineffective ITGCs in program change-management and job monitoring controls.
• ·Remediation completed in 2025 for prior material weaknesses in logical access controls, service organization control report reviews, and account reconciliations.
• ·Company qualifies as an emerging growth company and foreign private issuer under MJDS.

06-03-2026

Atlantis Glory Inc. (AGLY) reported zero revenue for FY 2025, unchanged from FY 2024, with net loss improving slightly to $39,199 from $40,480 (3% narrower YoY). However, total liabilities rose 23% to $210,628 from $171,429, driven by increased amounts due to related parties ($195,108 from $161,029), while stockholders' deficit deepened to $(210,628). The company holds zero assets and cash, fully reliant on related party financing to cover operating cash usage.

• ·Accumulated deficit increased to $(1,146,407) as of Dec 31, 2025 from $(1,107,208) as of Dec 31, 2024.
• ·Cash and cash equivalents remained at $0 at year-end for both 2025 and 2024.
• ·EPS basic and diluted flat at $(0.00) for both FY 2025 and FY 2024.
• ·Total assets $0 as of Dec 31, 2025 and 2024.

06-03-2026

Where Food Comes From, Inc. (WFCF) issued a proxy statement for its annual shareholder meeting on April 9, 2026, via conference call, seeking approval for electing six directors (including nominees John Saunders and Leann Saunders), ratifying Haynie as independent auditors (Proposal 2), advisory approval of executive compensation (Proposal 3), and a three-year frequency for future say-on-pay votes (Proposal 4). Record date is February 3, 2026, with 5,050,455 shares of common stock outstanding and eligible to vote. No financial performance data or period comparisons are provided in the filing.

• ·Meeting held via conference call: Domestic Toll Free 1-877-407-8289, International 1-201-689-8341, Conference Code 13759029.
• ·Proxy voting deadlines: Internet/telephone until 10:00 AM MT on April 9, 2026.
• ·Board recommends FOR all six director nominees, FOR auditor ratification, FOR say-on-pay, and THREE YEARS for frequency.
• ·Quorum requires majority of outstanding shares; Proposal 1 uses plurality vote.

06-03-2026

Adapti, Inc. (ADTI) announced the resignation of Marilu Brassington as CFO, principal accounting officer, and Board member effective March 2, 2026, with no disagreements noted; the separation agreement includes $15,000 in wages, up to $80,000 in contingent consulting fees tied to Reg A Offering fundraising milestones of $500,000 each, $60,000 in common stock, and accelerated vesting of 50,000 stock options. Adam Nicosia, the current CEO, was appointed interim principal financial and accounting officer effective the same date, leveraging his 18+ years of sales and marketing experience across brands generating over $500M in retail sales, with no additional compensation. The company retained an outside consulting firm to assist.

• ·Stock option exercise price: $3.08; originally granted August 14, 2025; exercisable until August 13, 2030
• ·Separation Agreement dated March 5, 2026; includes 7-day revocation period
• ·Transitional services from Ms. Brassington through March 31, 2026
• ·Filing date: March 6, 2026; earliest event: March 2, 2026

06-03-2026

FTAI Aviation Ltd. announced the immediate appointment of Nicholas McAleese as Chief Financial Officer and Michael Hazan as Chief Accounting Officer, succeeding Eun (Angela) Nam, who is departing after 12 years to pursue an opportunity outside the aviation industry and will assist in the transition. The company highlighted the new executives' internal experience and contributions since 2022 and 2017, respectively, while expressing thanks to Ms. Nam. No financial impacts or disruptions were mentioned.

• ·Nicholas McAleese joined FTAI in 2022 from roles at BHG Financial, Breather, and PwC.
• ·Michael Hazan joined in 2017, previously at Fortress Investment Group and PwC.
• ·Eun (Angela) Nam served FTAI for the last twelve years.

06-03-2026

Algonquin Power & Utilities Corp. (AQN) filed its Form 40-F annual report for the fiscal year ended December 31, 2025, incorporating the Annual Information Form, audited consolidated financial statements, and MD&A as exhibits. As of December 31, 2025, the company had 768,351,419 common shares outstanding and confirmed no off-balance sheet arrangements. The filing discloses the company's transition to a pure-play regulated utility since Q1 2025 following the sale of its renewable energy business (excluding hydro), with no specific period-over-period financial metrics provided in the Form 40-F itself.

• ·Designated Dilek Samil and Christopher Lopez as independent audit committee financial experts.
• ·Audited by Ernst & Young LLP (PCAOB ID: 1263).
• ·No off-balance sheet arrangements as of December 31, 2025.
• ·Discontinued presentation of certain non-GAAP metrics (Adjusted EBITDA, Adjusted Funds from Operations) post-sale of renewable energy business excluding hydro.

06-03-2026

Via Transportation, Inc. reported FY2025 revenue of $434.3M, up 29% YoY from $337.6M in 2024, driven by 31% Platform revenue growth to $434.3M (with Legacy revenue declining to $0 from $6.8M), customer count rising 23% to 821, and Platform ARR increasing 30% to $476M. Gross profit grew 31% to $171.8M with margin expansion to 40% from 39%. However, operating expenses rose 16% to $248.4M, narrowing operating loss to $76.6M from $83.9M but widening net loss to $96.4M from $90.6M due to a $10.9M loss on extinguishment of convertible notes.

• ·Stock-based compensation expense totaled $31.3M in FY2025, up 47% from $21.2M in FY2024.
• ·Interest expense increased to $7.3M in FY2025 from $4.3M in FY2024.
• ·FY2023 revenue was $248.9M, with net loss of $116.7M attributable to common stockholders.

06-03-2026

Nuveen AMT-Free Quality Municipal Income Fund extended the final mandatory redemption date of its Series 4 Variable Rate Demand Preferred Shares, aggregate liquidation preference $489.5M, from September 11, 2026, to September 11, 2056, effective March 5, 2026. The preferred shares feature weekly dividends set by a remarketing agent with a liquidity provision and are senior to common shares in liquidation and dividends. No performance declines or flat metrics were reported in this disclosure.

• ·Fund's fiscal year end is October 31.
• ·Series 4 shares are not registered under the Securities Act of 1933 and cannot be offered or sold without exemption.

06-03-2026

Jade Biosciences reported $336.2M in cash, cash equivalents, and investments as of December 31, 2025, up significantly from $69.4M at year-end 2024, following $180M in private placement proceeds, providing runway into H1 2028. Pipeline advances include JADE101 Phase 1 interim data in Q2 2026, Phase 2 initiation mid-2026, JADE201 first-in-human in Q2 2026, and JADE301 nomination with Phase 1 in H1 2027. However, R&D expenses rose 62% QoQ to $28.5M in Q4 2025 and 198% YoY to $93.1M for FY2025, G&A increased 167% QoQ to $6.4M and 374% YoY to $20.4M, driving net loss up 6% QoQ to $31.9M and 171% YoY to $127.4M.

• ·Total assets $349.8M as of Dec 31, 2025 (vs $72.8M Dec 31, 2024)
• ·Total liabilities $17.3M as of Dec 31, 2025 (down from $119.6M Dec 31, 2024)
• ·Stockholders’ equity $332.5M as of Dec 31, 2025 (vs deficit of $46.8M Dec 31, 2024)
• ·Company inception date June 18, 2024

06-03-2026

Genesco Inc. reported Q4 FY26 net sales of $800M, up 7% YoY from $746M, with comparable sales +9% driven by Journeys (+12%), while full-year FY26 sales rose 5% to $2.4B with comp sales +6%; operating income increased 11% to $51.3M in Q4 and 24% to $17.3M for the year on an adjusted basis. However, gross margins declined 100bps to 45.9% in Q4 and 90bps adjusted for FY26 due to promotions at Schuh and tariff pressures at Genesco Brands, with Brands sales down 27% in Q4 and 4% FY, Johnston & Murphy flat FY sales, and FY27 outlook showing total sales down 1% to flat despite 1-2% comp growth.

• ·E-commerce sales 31% of retail sales in Q4 FY26 (vs 30% prior), 25% FY26 (flat YoY).
• ·6 stores opened and 15 closed in Q4 FY26; net 42 store closings FY26.
• ·FY27 guidance: adj EPS $1.90-$2.30; tax rate ~30% (7-8% first three quarters due to valuation allowance).
• ·No share repurchases in Q4 FY26.

06-03-2026

Wheeler Real Estate Investment Trust, Inc. processed redemptions of 6,502 shares of Series D Cumulative Convertible Preferred Stock on March 5, 2026, at approximately $41.72 per share (including accrued dividends), settling via issuance of 143,914 shares of common stock at a volume-weighted average price of $1.88. This triggered a further adjustment to the conversion price of its 7.00% Subordinated Convertible Notes due 2031 to approximately $1.04 per share (24.12 shares per $25 principal), a 45% discount to $1.88. Cumulatively, 1,777,083 Series D shares have been redeemed with approximately 393,000 common shares issued; as of March 6, 2026, 1,433,983 common shares and 1,640,295 Series D shares remain outstanding.

• ·Next Series D redemption deadline: March 25, 2026; next Holder Redemption Date: April 6, 2026
• ·Redemption forms and FAQs available at https://ir.whlr.us/series-d/series-d-redemption

06-03-2026

Humana Inc. filed DEFA14A additional proxy materials on March 6, 2026, notifying employees and stockholders of the 2026 Annual Meeting on April 16, 2026, at 1:00 p.m. ET via virtual webcast at www.virtualshareholdermeeting.com/HUM2026. Retirement Savings Plan 401(k) participants with Humana Common Stock Fund shares as of the February 27, 2026 record date can vote by April 8, 2026, 11:59 p.m. EDT through Charles Schwab/Broadridge. Key proposals include election of 10 directors, ratification of PricewaterhouseCoopers LLP as auditors, advisory vote on executive compensation, approval of the 2026 Stock Incentive Plan, and a stockholder proposal on golden parachutes.

• ·Record date: February 27, 2026
• ·Proxy statement filed and available starting March 6, 2026
• ·Notice and Access Card mailing for non-electronic stockholders
• ·Stockholder materials request deadline: April 2, 2026
• ·General voting deadline: April 15, 2026, 11:59 PM ET
• ·ProxyVote.com control numbers: V83468-P45111, V83469-P45111
• ·Company address: 101 East Main Street, 10th Floor, Louisville, KY 40202
• ·Contact: CorporateSecretary@humana.com

06-03-2026

Western Alliance Bancorporation disclosed a material non-cash impairment charge of $126.4 million on March 2, 2026, due to counterparties breaching a commercial loan facility and forbearance agreement by failing to make a required $42.125 million principal payment and discontinuing future payments. The outstanding loan balance is $126.4 million, with the charge to be recognized in Q1 2026. The Bank has asserted claims and will pursue legal remedies for recovery, though outcomes remain uncertain amid forward-looking risks.

• ·Filing date: March 6, 2026
• ·Date of earliest event: March 2, 2026
• ·Securities: Common Stock (WAL), Depositary Shares WAL PrA on NYSE

06-03-2026

The Middleby Corporation (NASDAQ: MIDD) appointed Glenn Eisenberg to its Board of Directors effective March 1, 2026, expanding the board to twelve members. Eisenberg brings extensive experience as former CFO of Labcorp (a $13B global life sciences company) and The Timken Company, along with current board roles at Solventum (NYSE: SOLV) and Lumexa Imaging (NASDAQ: LMRI). CEO Tim FitzGerald and Chairman Gordon O’Brien highlighted his expertise in financial discipline, manufacturing, and capital allocation to support Middleby's strategic transformation in commercial foodservice.

• ·Eisenberg retired from Labcorp in December 2024 and continues as Special Advisor.
• ·Joined Solventum board in April 2024 (Audit Committee Chair); Lumexa Imaging in March 2025 (Audit and Compensation Committees).
• ·Previous roles: President and COO of United Dominion Industries; various senior finance roles at SPX Corporation.

06-03-2026

Total revenues grew 19.6% YoY to $1.36B in 2025 from $1.14B in 2024, with the Options segment driving growth to $1.11B (up 30.0% YoY), while Equities revenues declined 18.3% to $153M and International revenues fell 56.6% to $15M. Revenues less cost of revenues surged 56.2% to $431M, and Adjusted EBITDA increased 142.6% to $199M with a 46.2% margin, but GAAP net loss attributable to MIH was $70M versus $102M net income in 2024, driven by a $108M loss on debt extinguishment and other non-operating items. Operating income improved to $92M from a $2.8M loss, though Futures and Corporate/Other segments posted operating losses.

• ·Loss on extinguishment of debt: $108M in 2025
• ·Unrealized loss on derivative assets: $55M in International segment 2025
• ·Basic EPS: $(1.00) in 2025 vs $1.68 in 2024
• ·Adjusted diluted EPS: $1.82 in 2025 (up 193.5% YoY)
• ·Futures operating loss: $57M in 2025 (worsened from $47M loss in 2024)

06-03-2026

Prudential Financial, Inc.'s subsidiary, The Prudential Gibraltar Financial Life Insurance Co., Ltd. (PGFL), issued a press release on March 6, 2026, disclosing instances of unauthorized removal of information by certain PGFL employees seconded to financial institutions in Japan. The Company furnished an English translation of the press release as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure. No financial impacts or further details on the scope of the incident were provided.

• ·Filing signed by Brian P. Spitser, Vice President and Assistant Secretary.

06-03-2026

Altimmune, Inc. reported revenues of $41K for the year ended December 31, 2025, up 105% YoY from $20K, driven by minimal grant or collaboration income, while R&D expenses declined 19% to $66.4M, contributing to a reduced net loss of $88.1M (7% improvement) versus $95.1M in 2024. However, G&A expenses rose 34% to $28.1M, total cash increased to $43.8M supported by $207M in financing inflows despite $132M investing outflows and $68M operating cash burn.

• ·Shares outstanding increased to 110.9M from 72.4M YoY.
• ·Term loan noncurrent liability of $34.3M as of Dec 31, 2025 (none in 2024).
• ·Key audit matter on accrued R&D expenses ($6.1M) and prepaid R&D ($3.0M) as of Dec 31, 2025.
• ·Filing date: March 06, 2026.

06-03-2026

BCE Inc. filed its Form 40-F annual report for the fiscal year ended December 31, 2025, incorporating audited consolidated financial statements and MD&A via exhibits. The company acquired Ziply Fiber on August 1, 2025, which contributed 2% to consolidated revenues but negatively impacted net earnings by 1%. Disclosure controls and procedures were deemed effective as of December 31, 2025, excluding Ziply Fiber, with no material changes to internal controls over financial reporting.

• ·Common shares outstanding: 932,525,817
• ·Total First Preferred Shares outstanding: 131,755,879 across multiple series
• ·Ziply Fiber disclosure controls excluded from evaluation; full integration planned for Q3 2026
• ·Audit Committee comprises six independent members with three designated financial experts

06-03-2026

Immuneering reported 64% overall survival at 12 months in its ongoing Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients (N=34), well above the 35% GnP standard of care benchmark, with a favorable tolerability profile. Cash, cash equivalents, and marketable securities stood at $217M as of December 31, 2025, up significantly from $36.1M at year-end 2024, providing runway into 2029; R&D expenses declined 37% YoY to $9.3M in Q4 and 13% to $42M for FY2025. However, G&A expenses rose 22% YoY to $4.5M in Q4 and 8% to $17.3M for FY2025, contributing to a FY2025 net loss of $56M ($1.27/share), improved from $61M ($2.04/share) in FY2024 but still reflecting ongoing unprofitability.

• ·On track for expanded pancreatic cancer cohort data readout in 1H 2026.
• ·Dose first patient in Phase 3 MAPKeeper 301 trial mid-2026.
• ·Dosing in Phase 2 atebimetinib + Libtayo® NSCLC trial to begin 2H 2026.
• ·Added to Nasdaq Biotechnology Index on Dec 22, 2025.
• ·13.4 months median follow-up in Phase 2a trial as of Dec 15, 2025 data cutoff.

06-03-2026

United States Antimony Corporation (UAMY) filed an 8-K on March 6, 2026, under Item 3.01 notifying of delisting or failure to satisfy a continued listing rule or standard, a material negative development for shareholders. The filing also furnishes Exhibit 99.1, a press release under Item 7.01 (Regulation FD Disclosure), which includes forward-looking statements on the company's plans and potential benefits from a joint venture. No financial metrics or period comparisons were provided.

• ·Filing items include 3.01 (Notice of Delisting/Failure to Satisfy Rule), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits).
• ·Exhibit 99.1 is a Press Release dated March 6, 2026, furnished but not deemed 'filed' under the Exchange Act.

06-03-2026

Intensity Therapeutics, Inc. received a Nasdaq letter on March 5, 2026, confirming regain of compliance with Listing Rule 5550(a)(2) Minimum Bid Price Requirement after maintaining a $1.00 closing bid price for 10 consecutive business days from February 19 to March 4, 2026. This resolves prior notices from June 6, 2025 (initial 180-day period to December 3, 2025) and December 4, 2025 (extension to June 1, 2026). The company issued a press release on March 6, 2026, announcing the compliance.

• ·Initial Nasdaq deficiency notice issued June 6, 2025, for 30 consecutive business days below $1.00 bid price.
• ·Second Nasdaq letter on December 4, 2025, granted additional 180 calendar days until June 1, 2026.

06-03-2026

McKesson Corporation (MCK) filed a Form 8-K on March 6, 2026, under Items 7.01 and 9.01, announcing a news release issued the same day, attached as Exhibit 99.1, in compliance with Regulation FD. The filing details the company's registered securities, including common stock (MCK), 1.625% Notes due 2026 (MCK26), and 3.125% Notes due 2029 (MCK29). It was signed by Britt J. Vitalone, Executive Vice President and Chief Financial Officer.

06-03-2026

Signing Day Sports, Inc. (SGN) issued a Form 425 filing with a press release reminding stockholders of the special meeting on March 13, 2026, to vote on the proposed Business Combination with BlockchAIn Digital Infrastructure, Inc. and affiliates, originally agreed on May 27, 2025 and amended thereafter. Proxy materials were distributed to stockholders of record as of January 20, 2026, and upon approval, BlockchAIn shares are expected to trade on NYSE American under ticker 'AIB'. No financial metrics or performance data were disclosed in the filing.

• ·Special Meeting at 10:00 a.m. Pacific Time on March 13, 2026, at 8355 East Hartford Rd., Suite 100, Scottsdale, AZ 85255.
• ·Business Combination Agreement dated May 27, 2025; Amendment No. 1 dated November 10, 2025; Amendment No. 2 dated December 21, 2025.
• ·Previous disclosures in 8-K filings on May 28, 2025, November 12, 2025, and December 22, 2025.
• ·Proxy materials mailed as announced on February 17, 2026.

06-03-2026

Aptiv PLC announced that its subsidiary Aptiv Swiss Holdings Limited commenced a cash tender offer to purchase up to $1.35B aggregate consideration of several senior notes (including 3.250% due 2032, 5.150% due 2034, 5.750% due 2054, 4.400% due 2046, 4.150% due 2052, 3.100% due 2051, and 5.400% due 2032), conditional on the spin-off of its Electrical Distribution Systems business into Versigent and receipt of at least a $1.7B special dividend from Versigent. Separately, Aptiv announced conditional redemption of the entire $401M outstanding 4.650% Senior Notes due 2029 at a make-whole premium, expected on April 7, 2026, subject to the same conditions. No financial performance metrics were reported.

• ·Tender Offer to Purchase dated March 6, 2026
• ·Redemption of 2029 Notes expected April 7, 2026
• ·All transactions subject to Spin-Off consummation and $1.7B minimum special dividend

06-03-2026

PMV Pharmaceuticals reported a widened net loss of $77.7M for the year ended December 31, 2025, up 32% YoY from $58.7M in 2024, driven by a 19% increase in R&D expenses to $69.9M despite a 39% reduction in G&A expenses to $16.3M. Total operating expenses rose slightly by 0.9% to $86.2M, while cash and financial assets declined sharply 38% to $112.9M from $183.3M, with operating cash burn increasing 43% to $73.6M. Stockholders' equity decreased to $104.7M from $176.1M amid ongoing losses.

• ·Net loss per share was $1.48 basic and diluted for 2025, compared to $1.14 in 2024.
• ·Auditor emphasis on estimating R&D accruals and prepaids due to high subjectivity.
• ·Total assets decreased to $116.6M as of Dec 31, 2025 from $191.3M as of Dec 31, 2024.
• ·Accumulated deficit grew to $446.5M as of Dec 31, 2025 from $368.7M as of Dec 31, 2024.
• ·Filing date: March 06, 2026.

06-03-2026

For the nine months ended December 31, 2025, Virtuix Holdings Inc. reported net sales growth of 41% YoY to $3.0M and gross profit of $0.9M versus a $0.4M loss in the prior year, driven by lower cost of goods sold and sharply reduced operating expenses (G&A down 57% YoY); however, the net loss narrowed to $6.9M from $12.0M YoY amid high interest expense and debt extinguishment loss. Q3 2025 net sales declined 24% YoY to $1.0M, resulting in a $2.7M net loss versus $2.0M prior year, while selling expenses surged 199% YoY. Balance sheet reflects total assets up 10% to $6.4M with cash doubling to $1.1M, but current liabilities rose 48% to $8.7M due to increased notes payable, deepening stockholders' deficit to $3.0M from $0.8M.

• ·Preferred stock fully converted/reclassified to common stock by Dec 31 2025 (0 shares outstanding vs 21.7M at Mar 31 2025)
• ·Current notes payable doubled to $5.3M from $2.6M QoQ
• ·Inventory slightly down 5% QoQ to $1.4M
• ·Deferred revenue decreased 59% QoQ to $0.7M
• ·Financing activities: $3.0M from convertible notes, $1.9M preferred stock issuance
• ·Loss on debt extinguishment $123K in nine months 2025

06-03-2026

Reborn Coffee, Inc. increased its Board size from six to seven members on March 2, 2026, and appointed independent director Alex Yeon to fill the vacancy and serve on the Audit Committee with no compensation. On March 3, 2026, the Board appointed existing director Jung Jae Lim as Co-Chief Executive Officer alongside Jay Kim, with no additional compensation for Lim, who resigned from the Audit Committee due to loss of independence. Lim brings over 20 years of logistics and supply chain expertise from CEO roles at KCC Mexico Overseas Logistics, TJ America, and TJ Korea Inc.

• ·Alex Yeon determined independent under Nasdaq Rule 5605(a)(2).
• ·No family relationships or related party transactions involving Yeon or Lim.
• ·Jung Jae Lim received Bachelor of Language and Literature from Dankook University.
• ·Filing date: March 6, 2026; Event dates: March 2-3, 2026.

06-03-2026

AgEagle Aerial Systems Inc. (dba EagleNXT, NYSE: UAVS) announced a strategic investment in Israel's Aerodrome Group Ltd., a developer of precision loitering munitions, to boost capabilities in autonomy and precision strike technologies. The investment includes a reserved right for EagleNXT to establish a U.S.-based joint venture, subject to mutual agreement and regulatory approvals. This aligns with EagleNXT's mission in uncrewed systems for defense and other sectors, with CEO Bill Irby highlighting its role in enhancing security and operational effectiveness.

• ·EagleNXT’s platforms achieved FAA approvals for Operations Over People (OOP) and Beyond Visual Line of Sight (BVLOS)
• ·EASA C2 certification in Europe
• ·Inclusion on the U.S. Department of Defense’s Blue UAS list
• ·Forward-looking statements subject to risks including investment success and regulatory approvals for joint venture

06-03-2026

Cheniere Energy, Inc. (NYSE: LNG) announced its intention to offer Senior Notes due 2036 and Senior Notes due 2056, subject to market and other conditions. Proceeds from the offering will be used for general corporate purposes, including repayment or refinancing of existing indebtedness (such as under Cheniere Corpus Christi Holdings, LLC’s term loan facility), funding capital expenditures, working capital, and other business opportunities. The Notes will rank pari passu with Cheniere's existing senior notes due 2028 and due 2034; the offering is not registered under the Securities Act.

• ·Filing date: March 06, 2026
• ·Offer not registered under the Securities Act of 1933; may not be offered or sold in the US absent registration or exemption

06-03-2026

Hurco Companies reported a Q1 FY2026 net loss of $3.5M ($0.54/share), improved from $4.3M ($0.67/share) YoY, while sales and service fees declined 8% to $42.9M from $46.4M, with decreases across all regions: Americas -8%, Europe -5%, and Asia Pacific -15%. Orders increased 5% to $42.0M, led by 18% growth in Americas, but fell 2% in Europe and 6% in Asia Pacific; gross margin improved to 19% from 18%, though SG&A expenses rose to 26% of sales from 22%. Cash remained stable at $48.0M and working capital was $169.5M.

• ·Income tax expense $0.5M Q1 FY2026 vs $2.0M Q1 FY2025.
• ·Full valuation allowance recorded against Italian, U.S., and Chinese deferred tax assets as of Jan 31 2026.
• ·Inventory turns flat at 1.0x.
• ·Capital expenditures $0.6M Q1 FY2026 vs $0.6M Q1 FY2025.
• ·No total debt outstanding.
• ·Days sales outstanding 51 vs 42 QoQ.

06-03-2026

Stanley Black & Decker's 2026 Proxy Statement discloses no related party transactions since the start of fiscal 2025 and details non-employee director compensation for 2025, including an annual cash retainer of $125,000, annual RSUs valued at $200,000 (up from $185,000), and additional retainers for committee chairs and roles like Lead Independent Director ($45,000 aggregate RSUs). Total 2025 compensation ranged from $20,408 (prorated for new/short-term directors) to $649,955 (Andrea J. Ayers), with aggregate equity grant fair value of $1.76M; major shareholders include Vanguard (12.0%) and insiders own less than 1%. Human capital strategy is overseen by the CEO and CHRO, with annual talent reviews presented to the Board.

• ·No related party transactions requiring disclosure since beginning of fiscal 2025.
• ·Ownership data as of February 25, 2026; director changes include Laschinger joining November 1, 2025, Poul retiring at 2025 Annual Meeting.
• ·Chief Human Resources Officer (CHRO) reports to CEO; annual talent reviews with Compensation Committee and full Board.

06-03-2026

Adial Pharmaceuticals reported FY2025 financial results with cash and equivalents at $5.9M (up from $3.8M in FY2024), a reduced net loss of $8.0M (vs. $13.2M prior year, improved ~39%), R&D expenses down 19% ($609K decrease), but G&A expenses up 2% ($125K increase). The company advanced AD04 regulatory progress including positive FDA feedback and EOP2 meeting, expanded IP with patents through 2045, secured partnerships like Cytel and Genomind, U.S. manufacturing with Cambrex/Thermo Fisher, and a framework for $60M Europe deal with Molteni, while regaining Nasdaq compliance. Cash is projected to fund operations into H2 2026.

• ·Nasdaq compliance regained on Feb 24, 2026 (notice Feb 23, 2026), matter now closed.
• ·Molteni collaboration framework announced March 3, 2026, subject to definitive agreement.
• ·International patent application for AD04 published Jan 14, 2026 (filed July 2024), potential protection to 2045.
• ·Six-figure milestone payment received from Adovate on May 13, 2025 for Phase 1 trial of ADO-5030.

06-03-2026

NextTrip, Inc. (NTRP) announced on March 6, 2026, that it signed an agreement with J. Bradley Hilton’s Hilton Advisory Group to accelerate its premium wellness travel products across JOURNY.tv and Five Star Alliance. The press release is furnished under Item 7.01 (Regulation FD Disclosure) as Exhibit 99.1 and includes forward-looking statements regarding future performance.

• ·Filing includes Exhibit 99.1: Press Release dated March 6, 2026
• ·Registrant details: Nevada incorporation, Commission File Number 001-38015, IRS EIN 27-1865814, address 3900 Paseo del Sol, Santa Fe, New Mexico 87507

06-03-2026

Allarity Therapeutics, Inc. entered into a Notes Purchase Agreement dated March 2, 2026, with Streeterville Capital, LLC, agreeing to issue and sell a Promissory Note A-1 with $10.93M principal (including $900k OID and $30k transaction expenses) and a secured Promissory Note B with $10M principal, for a total purchase price of $20M. The B Note is secured by cash collateral in a Deposit Account at Lakeside Bank under a DACA and Pledge Agreement, with obligations guaranteed by subsidiaries ALLR Holdings, LLC, Allarity Acquisition Subsidiary, Inc., and Allarity Therapeutics Europe ApS. The agreement includes restrictive covenants on new debt, liens, equity issuances, and SEC reporting requirements.

• ·Closing Date: March 2, 2026
• ·A-1 Note cash payment: $10M directly to Company
• ·B Note cash payment: $10M to Lakeside Bank under DACA
• ·Transaction relies on Section 4(a)(2) of 1933 Act and Rule 506(b)
• ·Covenants prohibit Restricted Issuances, new liens/encumbrances, equity sales in subsidiaries, and require timely SEC filings and listing maintenance

06-03-2026

Mammoth Energy Services reported Q4 2025 revenue from continuing operations of $9.5M, down 5% YoY from $10.0M and 13% QoQ from $10.9M, with full-year revenue at $44.3M, down 3% YoY from $45.6M; net loss widened to $12.3M in Q4 (vs $9.6M YoY) but improved FY to $63.8M from $183.1M. While rental services revenue surged 175% YoY to $3.3M and infrastructure grew 200% to $1.2M, natural sand proppant declined 67% YoY to $1.7M and accommodation fell 17% FY YoY; Adjusted EBITDA remained negative at ($6.8M) Q4, though FY improved significantly to ($17.4M). Four divestitures generated over $150M in cash, bolstering liquidity to $158.3M at year-end, with $65M+ deployed into high-growth aviation rentals.

• ·SG&A expense FY 2025: $19.6M vs $114.5M in 2024 (83% decline, due to lower expected credit losses on PREPA settlement).
• ·Drilling services FY revenue flat at $3.7M vs $3.6M YoY (+3%).
• ·As of Mar 3, 2026, total liquidity $156.6M (cash $89.6M, marketable securities $28.8M).
• ·Q4 sand avg sales price $18.56/ton vs $22.54 YoY (-18%).

06-03-2026

Cohen & Company Inc. reported strong Q4 and FY 2025 results with total revenue of $102.7M in Q4 (up 454% YoY from $18.5M) and $275.6M for FY (up 246% YoY from $79.6M), driven by investment banking ($54.7M in Q4, up 568% YoY but down 20% QoQ) and principal transactions ($31.5M in Q4). Net income attributable to the company was $8.1M ($1.48/share) in Q4 and $14.4M ($4.35/share) for FY, versus a FY 2024 loss; however, asset management revenue declined slightly 2% YoY to $8.8M for FY, and losses from equity method affiliates widened to $16.8M for FY. The board declared a $0.25 quarterly dividend and $0.70 special dividend per share, payable April 3, 2026.

• ·CCM ranked number one in SPAC IPO underwritings by left book run deals and in de-SPAC advisory per SPAC Research.
• ·Q4 principal transactions revenue included $33.0M from Columbus Circle Capital Corp I and ProCap Financial business combination.
• ·Loss from equity method affiliates was $5.1M in Q4 2025 vs $12.7M in Q3 2025 and $0.7M in Q4 2024.
• ·Income tax benefit of $2.3M in Q4 2025 included $2.8M deferred tax benefit from valuation allowance reduction.
• ·Prior special dividend of $2.00 per share announced Dec 2025 and paid Jan 2026.
• ·Conference call held March 6, 2026 at 10:00 a.m. ET.

06-03-2026

The Goodyear Tire & Rubber Company's DEF 14A proxy statement outlines its corporate governance practices, including a separated Chairman (Ms. Koellner) and CEO (Mr. Stewart) roles since January 29, 2024, with 83% independent director nominees and full independence on key committees. The Board oversees risks through committees, with 2025 meeting counts of 6 for the full Board and 5, 4, 3, 4, and 0 for Audit, Human Capital & Compensation, Corporate Responsibility & Compliance, Finance, and Governance committees, respectively, alongside emphasis on management succession and the Goodyear Forward transformation plan. No financial performance metrics or declines are discussed.

• ·Board leadership separation effective since January 29, 2024; Ms. Koellner served as Lead Director from June 30, 2019 to January 29, 2024.
• ·Mr. Wessel appointed director in December 2005 via USW nomination.
• ·Governance Committee considers director nominees based on integrity, experience, diversity, and independence standards.

06-03-2026

Eightco Holdings Inc. (ORBS) filed an 8-K on March 6, 2026, under Items 7.01 and 9.01, disclosing a press release providing an operational update, attached as Exhibit 99.1 and furnished pursuant to Regulation FD. The information is explicitly not deemed 'filed' under the Exchange Act or subject to its liabilities. No specific financial or operational metrics were detailed in the filing.

• ·Registrant is an emerging growth company.
• ·Common Stock: $0.001 par value, traded as ORBS on Nasdaq.
• ·Principal executive offices: 101 Larry Holmes Drive Suite 313, Easton, PA 18042.

06-03-2026

Future Vision II Acquisition Corp. (FVNNR), a SPAC, filed its 10-K annual report for the year ended December 31, 2025, highlighting ongoing risks related to completing an initial business combination within 18-24 months from IPO closing, potential conflicts of interest among officers and directors, and PRC-related regulatory hurdles. The filing details acquisition criteria focused on revenue growth, free cash flow generation, and public company benefits but notes no business combination has occurred, with financial statements covering the period from inception (January 30, 2024). Risks include dilution from convertible loans up to $1.5M and founder shares purchased at $0.017 per share.

• ·Financial statements cover year ended December 31, 2025 and period from January 30, 2024 (inception) through December 31, 2024.
• ·Initial business combination deadline: 18 months from IPO closing (extendable to 24 months).
• ·PRC regulatory risks including data security oversight by Cyberspace Administration of China and potential need for approvals.

06-03-2026

GXO Logistics, Inc. appointed Mark Suchinski as Chief Financial Officer effective April 1, 2026, bringing over three decades of finance, operations, and supply chain experience, particularly in aerospace and defense. CEO Patrick Kelleher stated that the leadership team is now fully in place to drive faster growth and higher margins. The company operates over 150,000 team members across more than 1,000 facilities totaling more than 200 million square feet.

• ·Mark Suchinski previously served as CFO for The GEO Group, Inc. and Spirit AeroSystems.
• ·Patrick Kelleher joined GXO in August 2025.
• ·Suchinski holds a Bachelor of Business Administration from DePaul University.

06-03-2026

ASP Isotopes Inc. issued a press release on March 6, 2026, announcing a memorandum of understanding (MOU) between Quantum Leap Energy LLC and a large U.S. energy company to evaluate support for advancing the enriched uranium fuel supply chain in the United States. No financial terms or quantitative impacts were disclosed in the filing.

• ·Filing date: March 6, 2026
• ·Items reported: 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)

06-03-2026

Deric Eubanks voluntarily terminated his employment with Ashford Hospitality Advisors, LLC effective March 31, 2026, without Good Reason, in exchange for a $1.8M Non-Compete Payment paid over 12 months, a $0.2M transition payment through June 30, 2026, continuation of $3.3M deferred cash grants vesting per original schedule, and eligibility for a prorated 2025 Cash Incentive Bonus aligned with AINC executives. He will provide up to 40 hours/month consulting and 20 hours/week part-time transition assistance remotely. The agreement includes mutual general releases, non-disparagement, and reaffirmed restrictive covenants including 12-month non-compete and 24-month non-solicitation periods.

• ·Consulting services: up to 40 hours per month remotely during deferred cash grants vesting period.
• ·Transition assistance: up to 20 hours per week remotely from March 31 to June 30, 2026.
• ·Non-compete period: 12 months post March 31, 2026.
• ·Non-solicitation and standstill periods: 24 months post March 31, 2026.
• ·Original Employment Agreement effective January 1, 2023.
• ·Payments subject to 8-day revocation period; Non-Compete Payment starts first payroll in April 2026.

06-03-2026

ArteLo Biosciences, Inc. (ARTL) filed an 8-K on March 6, 2026, reporting material modifications to the rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing falls under the subcategory of Charter/Bylaws Amendments, indicating potential changes to corporate governance structure. No financial metrics or period-over-period comparisons were disclosed in the available filing details.

• ·Filing accession number: 0001640334-26-000395
• ·Company CIK: 0001621221
• ·SIC: 2834 (Pharmaceutical Preparations)
• ·Incorporated in NV, located in CA, Fiscal Year End: December 31
• ·Former names: Knight Knox Development Corp. (through 2017-02-06), Reactive Medical Inc. (through 2017-04-17)

06-03-2026

Deric Eubanks voluntarily terminates employment with Ashford Hospitality Advisors, LLC on March 31, 2026, without Good Reason, in exchange for a release and waiver agreement. He receives a $1.8M Non-Compete Payment paid over 12 months, $200K transition payment through June 30, 2026, eligibility for a prorated 2025 Cash Incentive Bonus, and continued vesting of $3.3M in deferred cash grants and 13,490 AINC shares subject to compliance with consulting and restrictive covenants. Mutual releases, non-disparagement, and ongoing non-compete (12 months), non-solicitation (24 months) obligations are affirmed.

• ·Non-compete period: 12 months post-termination
• ·Non-solicitation and standstill periods: 24 months post-termination
• ·Payments subject to 8-day revocation period and compliance with consulting (remote, reasonable requests)
• ·Original employment agreement effective January 1, 2023

06-03-2026

Warner Music Group Corp. held its Annual Meeting of Stockholders on March 3, 2026, electing all eleven director nominees with overwhelming support (For votes ranging from 7.55B to 7.63B shares out of approximately 7.64B total votes cast, minimal Against votes under 80M). Stockholders also ratified KPMG LLP as the independent registered public accounting firm for fiscal year 2026 with 7.63B For votes and negligible opposition (13.3M Against). No broker non-votes for Proposal 2, indicating strong consensus.

• ·Proxy statement filed with SEC on January 20, 2026.
• ·Proposal 1 broker non-votes: 11,989,796 shares.
• ·Proposal 2: Against 13,299,930 shares; Abstain 33,513 shares.

06-03-2026

Clover Health Investments, Corp. (CLOV) published written responses to a selection of frequently asked supplemental shareholder questions related to its fourth quarter 2025 earnings announcement on March 6, 2026. The Q&A is furnished as Exhibit 99.1 to this Form 8-K and available on the company's investor relations website. This disclosure is pursuant to Regulation FD and not deemed 'filed' for purposes of the Exchange Act.

• ·Related to fourth quarter 2025 earnings announcement.
• ·Securities registered: Class A Common Stock, par value $0.0001 per share (CLOV).
• ·Remote-first company with no physical headquarters; communications to secretary@cloverhealth.com.